Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Vanderbilt’s Innovation Ambassadors help their colleagues change the world

    ... technology to improve the diagnosis of early-stage lung cancer. An extension of long-standing, campuswide efforts to encourage ... Builders Program , which supports the devising of  new content and tools for VUMC’s health and information technology system. ...

    sommers - 04/29/2024 - 11:58am

  2. Tech Connect, Vol. 6, Issue 22: CTTC team presents, participates at 2016 SEMDA meeting

    ... with a mid-sized pharmaceutical company to discuss anti-cancer compounds developed by Stephen Fesik from the Department of ... working with Vanderbilt and contributing to the educational content and advising within the Innovation Center . ...

    steelmk - 11/10/2016 - 7:45am

  3. mGlu3 NAMs as Therapeutics for Chemoresistant Tumors

    ... has been shown to enhance the chemosensitivity of colorectal cancer stem cells to standard cytotoxic chemotherapy (Neuroscience Poster, ... Small Molecule Featured:  0 Priority:  1 Case manager:  ...

    cttc_admin - 01/23/2024 - 4:42pm

  4. Tech Connect, Vol. 7, Issue 17: Medical Device Lunch and Learn

    ... Director of  AdvaMed Accel , will be our featured speaker. She will discuss: “How the role of ... with a representative from the Freedom from Cancer Challenge to learn more about their initiative to start 100 companies ...

    steelmk - 07/21/2017 - 3:29pm

  5. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... T cell therapies have emerged as an effective treatment for cancer and potentially other cardiometabolic and autoimmune diseases. However, ... Cellular Therapy Featured:  0 Priority:  0 Case manager:  ...

    cttc_admin - 01/18/2024 - 9:10am

  6. Tech Connect, Vol. 7, Issue 23: Vanderbilt-GSK DPAc Request for Proposals

    ... the technology is currently being investigated for breast cancer margin detection. ... meet with local and regional investors. The conference also featured a student pitch competition that was won by Vanderbilt startup PATH ...

    steelmk - 07/21/2017 - 3:41pm

  7. The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck

    ... Amgen, AstraZeneca, Bayer, and Merck will co-fund the whole-genome sequencing (WGS) of 250,000 samples and have access to the resulting ... associations and targets for intervention by analyzing whole-genome sequence data derived from Vanderbilt University Medical Center's ...

    sommers - 07/20/2023 - 10:17am

  8. Current Request for Proposals

    ... or glycanreceptors, preclinical models torecapitulate cancer biology ... will be reviewed for the quality of their scientific content, creativity, and potential for impact at scale. Proposals related to ...

    cttc_admin - 12/13/2023 - 4:47pm

  9. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... THER) (“Theralink” or the “Company”) , a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announced that it has acquired an exclusive license from ...

    sommers - 04/24/2023 - 1:45pm

  10. Novel Targets Involved in Ferroptosis for Therapeutic Development in Oncology

    ... April 2, 2024 - 12:00am Cumulus Oncology is developing anti‑cancer therapies for clinical settings in areas of high unmet need, with the ...

    cttc_admin - 03/14/2024 - 6:11pm